| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/18/2002 | WO2002030435A1 Treatment of t cell disorders |
| 04/18/2002 | WO2002030434A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 04/18/2002 | WO2002030433A2 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 04/18/2002 | WO2002030351A2 Improvement of graft acceptance through manipulation of thymic regeneration |
| 04/18/2002 | WO2002030320A2 Stimulation of thymus for vaccination development |
| 04/18/2002 | WO2002030259A2 Disease prevention by reactivation of the thymus |
| 04/18/2002 | WO2002030257A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 04/18/2002 | WO2002030256A2 Diagnostic indicator of thymic function |
| 04/18/2002 | WO2002030206A1 Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction |
| 04/18/2002 | WO2002030190A1 Method of inactivating viral particles in a blood product |
| 04/18/2002 | WO2002013760A3 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 04/18/2002 | WO2002011742A3 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 04/18/2002 | WO2002007742A9 Bacteriophage having multiple host range |
| 04/18/2002 | WO2002007738A8 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 04/18/2002 | WO2002004596A3 Diagnosing and treating cancer cells using mutant viruses |
| 04/18/2002 | WO2001083707A3 Chondrocyte cultures and anti-angiogenic fractions therefrom |
| 04/18/2002 | WO2001079452A3 Tolerance-inducing thy-marrow composite tissue construct and organ |
| 04/18/2002 | WO2001066699A3 P27 and p21 in gene therapies |
| 04/18/2002 | WO2001060400A3 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/18/2002 | WO2001058483A3 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 04/18/2002 | WO2001051631A3 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 04/18/2002 | WO2001049824A3 Cell growth substrate hydrogels |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2000073482A9 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 04/18/2002 | WO2000073417A9 In vitro cell culture device including cartilage and methods of using the same |
| 04/18/2002 | US20020045940 Methods, instruments and materials for chondrocyte cell transplantation |
| 04/18/2002 | US20020045735 Isolating glycoproteins from solution; obtain sample, homogenize, incubate with acetic acid, recover preferential glycoproteins |
| 04/18/2002 | US20020045593 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons |
| 04/18/2002 | US20020045587 Attenuated bacteria transformed with a promoter activated in cytosol of a host cell to produce a polypeptide lethal to the bacterium, and a host cell compatible promoter coding for therapeutic polypeptide such as an antigen; vaccination |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045261 Genetically engineered cells for use in the treatment of tumors; antitumor agents |
| 04/18/2002 | US20020045260 Recovering preferential progenitor cells; provide mixture of progenitor cells, incubate in culture apparatus, recover and propagate cells |
| 04/18/2002 | US20020045258 Methods to prepare and use epidermal stem cells |
| 04/18/2002 | US20020045256 Method for enhancing primordial germ cell number |
| 04/18/2002 | US20020045252 Activating cells associated with preventing immune response; obtain cells, incubate with immunomodulator, monitor cell for immune response |
| 04/18/2002 | US20020045241 T cells specific for kidney carcinoma |
| 04/18/2002 | US20020045240 Solid phase extraction of the sources containing the components to be separated on anion exchanger materials in loose bulk, on membranes and/or on compact disks,removal of effluent; elution of adsorbed material, fractionation |
| 04/18/2002 | US20020044990 Baked good comprising a non-baked fat-based composition and a baked part; fat-based composition is water-free and comprises live lyophilized lactic bacteria; baked part comprises non-digestible fibre-like substances |
| 04/18/2002 | US20020044952 Attenuated live neospora vaccine |
| 04/18/2002 | US20020044942 Transfer factor composition and process for producing same |
| 04/18/2002 | US20020044926 Or other probiotic organisms, such as Bifidobacterium, for improving vaginal health, to treat vaginitis, bacterial vaginosis and reduce candida colonization |
| 04/18/2002 | US20020044925 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 04/18/2002 | US20020044924 Extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells to patient; T-cell- mediated and inflammatory disorders |
| 04/18/2002 | US20020044923 Modulating immune responses using antigen presenting human mesenchymal stem cells to induce specific T cell anergy |
| 04/18/2002 | US20020044922 Recombinant phages |
| 04/18/2002 | US20020043492 Systems and methods for on line finishing of cellular blood products like platelets harvested for therapeutic purposes |
| 04/18/2002 | CA2462758A1 Diagnostic indicator of thymic function |
| 04/18/2002 | CA2462681A1 Disease prevention by reactivation of the thymus |
| 04/18/2002 | CA2462671A1 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 04/18/2002 | CA2462073A1 Hematopoietic stem cell gene therapy |
| 04/18/2002 | CA2462046A1 Improvement of graft acceptance through manipulation of thymic regeneration |
| 04/18/2002 | CA2462027A1 Stimulation of thymus for vaccination development |
| 04/18/2002 | CA2425835A1 Methods and compositions for nucleic acid delivery |
| 04/18/2002 | CA2425815A1 Treatment of t cell disorders |
| 04/18/2002 | CA2425779A1 Compositions that inhibit proliferation of cancer cells |
| 04/18/2002 | CA2422718A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 04/17/2002 | EP1197496A1 Novel peptides |
| 04/17/2002 | EP1197218A1 Algae protein polysaccharide extraction and use thereof |
| 04/17/2002 | EP1197147A1 Method of inactivating viral particles in a blood product |
| 04/17/2002 | EP1196778A1 Method and kit for immuno-detecting bacteria in blood and tissues |
| 04/17/2002 | EP1196635A2 Cell death related drug targets in yeast and fungi |
| 04/17/2002 | EP1196618A2 Novel vector complexes and their use in gene therapy |
| 04/17/2002 | EP1196616A2 Replication-competent anti-cancer vectors |
| 04/17/2002 | EP1196608A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 04/17/2002 | EP1196607A1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 04/17/2002 | EP1196584A1 Tetanus toxin polypeptides |
| 04/17/2002 | EP1196575A2 Gtp-binding protein associated factors |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196565A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/17/2002 | EP1196560A1 Neurotrophic factor receptor gfr-alpha-4 |
| 04/17/2002 | EP1196543A2 Treatment of dendritic cells for induction of immune tolerance |
| 04/17/2002 | EP1196541A2 Storage of microorganisms, cells and tissue |
| 04/17/2002 | EP1196540A2 Scaffold matrix and tissue maintaining systems |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196439A2 Compounds exhibiting an antibiotic activity |
| 04/17/2002 | EP1196435A1 Recombinant adenovirus |
| 04/17/2002 | EP1196426A1 Cytoplasmic transfer to de-differentiate recipient cells |
| 04/17/2002 | EP1196185A1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions |
| 04/17/2002 | EP1196182A2 Method for enhancing production performance in an animal |
| 04/17/2002 | EP1196047A1 Prophylactic dietary supplement based on milk |
| 04/17/2002 | EP1196030A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 04/17/2002 | EP1196029A2 A device and method for performing a biological modification of a fluid |
| 04/17/2002 | EP1007561B1 Novel conjugates of opioids and endogenous carriers |
| 04/17/2002 | EP0889721B1 Remedy for external application, and use of an oil-in-water emulsion for said remedy |
| 04/17/2002 | EP0853890B1 Lactose-containing food composition for infants |
| 04/17/2002 | EP0794790B1 Localized delivery of factors enhancing survival of transplanted cells |
| 04/17/2002 | EP0707485B1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/17/2002 | EP0580606B1 Method for delivering the direct feed microorganism lactobacillus reuteri to avian organisms in ovo |
| 04/17/2002 | CN1345376A Protease, gene therefor and use thereof |
| 04/17/2002 | CN1345374A HER-2/neu fusion proteins |
| 04/17/2002 | CN1345336A Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345242A Method for treatment of leukaemia |
| 04/17/2002 | CN1345234A Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain |
| 04/17/2002 | CN1344563A Medicine for treating hepatitis B and other hepatosis |
| 04/17/2002 | CN1344558A Bone invigorating composition containing yak bone and its prepn |
| 04/17/2002 | CN1344557A Kidney invigorating and arthralgia eliminating granule |
| 04/17/2002 | CN1344556A Bladder cancer treating Chinese medicine |
| 04/17/2002 | CN1344555A Pure Chinese medicine prepn for treating erection mulfunction |
| 04/17/2002 | CN1344554A Deafness and tinnitus treating Chinese medicine and its prepn |